MVA85A vs placebo
Adverse events of any severity · HIV‐positive and ‐negative adults and children
MVA85A leads to higher adverse events of any severity compared with placebo (high certainty).
1 finding from 1 review
- RR 1.05 [1.02, 1.08]4 studies · 3836 participantsHigh